American Society of Clinical Oncology

SHERPA: White

People

  1. Dang
    Dang
  2. Hudis
    Hudis
  3. Iyengar
    Iyengar
  4. Norton
    Norton
  5. Chandarlapaty
    Chandarlapaty
  6. Modi
    Modi
  7. Traina
    Traina
  8. Troso-Sandoval
    Troso-Sandoval
  9. Comen
    Comen
  10. Drullinsky
    Drullinsky

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Breast Medicine Service (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. Population Sciences Research Program (4)
  6. Solid Tumor Oncology Division (4)
  7. Survivorship Research (4)
  8. Biostatistics Service (3)
  9. GDMT, Medicine (2)
  10. GSK Faculty (2)
Search Within
  1. "Larry Norton"
  2. "Lillian Smyth"
Formats
  1. Meeting Abstract (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Breast Medicine Service (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. Population Sciences Research Program (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Chau Dang (4)
  2. Clifford Hudis (4)
  3. Jose Baselga (4)
  4. Larry Norton (4)
  5. Lillian Smyth (4)
  6. Neil Iyengar (4)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2015 (2)
Publications
  1. Journal of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
    Meeting Abstract

    Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save